BAJAJ BROKING

Notification close image
No new Notification messages
card image
Seshaasai Technologies Ltd IPO
Apply for the Seshaasai Technologies Ltd IPO through UPI in Just minutes
delete image
card image
Start your SIP with just ₹100
Choose from 4,000+ Mutual Funds on Bajaj Broking
delete image
card image
Open a Free Demat Account
Pay ZERO maintenance charges for the first year, get free stock picks daily, and more.
delete image
card image
Trade Now, Pay Later with up to 4x
Never miss a good trading opportunity due to low funds with our MTF feature.
delete image
card image
Track Market Movers Instantly
Stay updated with real-time data. Get insights at your fingertips.
delete image
Active
Mainboard

Gujarat Kidney & Super Speciality Ltd

Gujarat Kidney & Super Speciality Ltd IPO Details

Listing Date

30 Dec 2025

Bid Price

₹108 - ₹114

Lot Size

128 Shares

Minimum Investment

₹14,592 / Lot

Issue Size

₹250.8 Crores

Schedule

    Here are the important dates you need to know in order to participate in this IPO

tick

Bidding starts

22nd Dec

tick

Bidding ends

24th Dec

tick

Allotment of shares

26th Dec

tick

Initiation of refund

29th Dec

tick

Credit of shares to Demat account

29th Dec

tick

Listing date

30th Dec

About Gujarat Kidney & Super Speciality Ltd IPO

Gujarat Kidney and Super Speciality Limited (GKASSL), incorporated in 2019, offers multispeciality healthcare services across several locations in Gujarat. The organisation provides both secondary and tertiary care through a network of hospitals and pharmacies. As of June 30, 2025, it operates seven multispeciality hospitals and four pharmacies with a total bed capacity of 490 beds, an approved capacity of 445 beds, and an operational capacity of 340 beds. Its healthcare facilities include Gujarat Kidney and Superspeciality Hospital in Vadodara, Gujarat Multispeciality Hospital in Godhra, Raj Palmland Hospital Private Limited in Bharuch, M/s Surya Hospital and ICU in Borsad, Gujarat Surgical Hospital in Vadodara, Ashwini Medical Centre in Anand, Ashwini Medical Store in Anand, and Apex Multispeciality & Trauma Center in Bharuch. The company’s medical team comprises 89 doctors, 332 nurses, and 338 other staff members.

 

The organisation provides a range of medical services that cover secondary care such as general and surgical treatments, along with tertiary care offerings involving super-speciality procedures. Its hospitals provide treatment in internal medicine, general surgery, minimally invasive procedures, orthopaedics, trauma care, joint replacement, obstetrics and gynaecology, respiratory conditions, non-interventional cardiology, diabetology, and anaesthesiology. With a network of mid-sized multispeciality hospitals, GKASSL delivers integrated healthcare services across the central region of Gujarat. The company’s operational model focuses on addressing various healthcare requirements through its distributed network of hospitals and associated pharmacies, enabling it to cater to a broad and diverse patient base within its service regions.

Shareholder Pattern

  Pre-Issue Post-Issue
Promoter Group 99.1% 71.45%
Public Group 0.9% 28.55%

Gujarat Kidney & Super Speciality Ltd IPO Reservation

QIB Shares Offered 66,00,000 (30%)
NII (HNI) Shares Offered 33,00,000 (15%)
Retail Shares Offered 22,00,000 (10%)
Anchor Investor Shares Offered 99,00,000 (45%)
Total Shares Offered 2,20,00,000
Total Shares With Anchor Investor 2,20,00,000

Gujarat Kidney & Super Speciality Ltd IPO Lot Size

Application Lots Shares Amount
Retail (Min) 1 128 ₹14,592
Retail (Max) 13 1,664 ₹1,89,696
S HNI (Min) 14 1,792 ₹2,04,288
S HNI (Max) 68 8,704 ₹9,92,256
B HNI (MIN) 69 8,832 ₹10,06,848

Gujarat Kidney & Super Speciality Ltd IPO Anchor Investor Details

Bid Date December 19, 2025
Shares Offered true
Anchor Investment Details 100.013568

Gujarat Kidney & Super Speciality Ltd IPO registrar

MUFG Intime India Pvt Ltd
Phone Number +91 810 811 4949
Email Id gujaratkidney.ipo@in.mpms.mufg.com
Website https://in.mpms.mufg.com

Gujarat Kidney & Super Speciality Ltd IPO Lead Manager

1. Nirbhay Capital Services Pvt ltd

Gujarat Kidney & Super Speciality Ltd Financial Information

March 31, 2025 March 31, 2024 March 31, 2023
Net Worth ₹25.94 cr ₹10.8 cr ₹0.37 cr
Reserves and Surplus ₹14.57 cr ₹10.6 cr ₹0.17 cr
Total Borrowing ₹3.88 cr ₹1.94 cr ₹0 cr

Gujarat Kidney & Super Speciality Ltd IPO Subscription LIVE Status

Category No. of shares offered No. of shares bid No. of subscribed
Qualified Institutional Buyers (QIBs) 77,26,880 26,60,480 0.3443
Non Institutional Investors (NIIs) 33,00,000 97,21,984 2.9461
NII(Bid amount of more than Ten Lakh Rupees) 22,00,000 69,95,840 3.1799
NII(Bid amount of more than 2 Lakh < 10 Rupees) 11,00,000 27,26,144 2.4783
Retail Individual Investors (RIIs) 22,00,000 2,29,90,080 10.45
Total 1,32,26,880 3,53,72,544 2.67

Strength of Gujarat Kidney & Super Speciality Ltd

  • Pre-eminence in renal sciences, with established sub-superspecialties in urology and strong capabilities in other specialties.
  • `Right-sized', full service and strategically located hospitals leading to high return on capital.
  • Ability to attract, train and retain quality medical professionals.
  • Investment in infrastructure, processes and clinical excellence driving affordability, and a strong value proposition for stakeholders.
  • Track record of operating and financial performance and growth.
  • Professional management and experienced leadership.

Risks Involved

  • The company proposes to use a portion of the Net Proceeds from the Issue for acquisition of Parekhs Hospital Private Limited, following which the Company will be responsible for overseeing and managing the Parekhs Hospital. Its may face difficulties in completing the acquisition within the terms mentioned in term sheet, affecting the company future plans and prospects.
  • The Company proposes to utilise a portion of the Net Proceeds from the Issue towards making part-payment of purchase consideration for the acquisition of Ashwini Medical Centre, pursuant to the Acquisition Agreement. In case of delay in raising funds from the Issue, its may face challenges in paying the consideration to sellers of Ashwini Medical Centre.
  • The company proposed plans with respect to funding the capital expenditure requirement for construction of new hospital are subject to the risk of unanticipated delays in obtaining approvals and implementation which may adversely affect its business and results of operations. Further, the company are yet to place orders for such capital expenditure requirements. There is no assurance that its would be able to source such capital expenditure requirements in a timely manner or at commercially acceptable prices, which could adversely affect the company expansion plans. Its may be unsuccessful in implementing the company growth plans of expansion in Gujarat, India in a timely manner or at all, which may have an adverse effect on its business, financial condition and results of operations. Furthermore, the proposed construction of the new hospital is planned to be carried out on leased land, which includes potential challenges or risks related to the terms of lease arrangement, could have adverse effect on the company business, financial position, and results of operations.
  • The Company has acquired Harmony Medicare Private Limited, subsequent to the three month period ended June 30, 2025. As its Company and Harmony Medicare Private Limited were separate entities operating independently from each other prior to June 30, 2025, the Restated Financial Statements does not include the financial information pertaining the said acquisition. Hence, the company Restated Financial Statements for the three month period ended June 30, 2025 and the Financial Years ended March 31, 2025, March 31, 2024 and March 31, 2023, are not analogous and comparable to any future financial results/statements that its may prepare.
  • The company have assumed customary liabilities pursuant to its recent acquisitions. Any liabilities beyond the company estimates may materially and adversely impact its business, financial condition, cash flows, results of operations and the trading price of the company Equity Shares.
  • The company hospitals face potential reputational damage and financial consequences from any failure to provide Quality medical treatment or service. Additionally, its are exposed to operational, reputational, and legal risks, including malpractice or medical negligence claims, which could adversely impact the company reputation, operations, and financial stability.
  • Any variation in the utilisation of the Net Proceeds would be subject to certain compliance requirements, including prior shareholders' approval
  • If the company fail to achieve favourable pricing on medical consumables, pharmacy items, drugs, and surgical instruments from its suppliers or are unable to pass on any cost increases to the company payers, its profitability could be materially and adversely affected.
  • The company Promoters have extended personal guarantees with respect to loan facilities availed by its Company. Revocation of these personal guarantees may adversely affect the company business operations and financial condition.
  • Some of the company doctors are not its employees. If such doctors discontinue their association with the company or are unable to provide their services at its centres or hospitals for any reason or if the company are unable to attract or retain such doctors and other healthcare professionals, its business and results of operations may be materially and adversely affected.
stock

Invest in IPOs with ease

Sign-in to invest with your demat account, or set up a new demat account for free

Industry Outlook of Gujarat Kidney & Super Speciality IPO

  • The D&B Report indicates that public spending on healthcare infrastructure in India has been rising, reflecting continued efforts to strengthen the national healthcare framework.

  • Government expenditure on health was around 1.9% of the GDP in 2023–24, compared with about 1.28% in 2018–19.

  • As outlined in the National Health Policy, there is an official objective to increase public health spending to 2.5% of GDP by 2025.

  • This steady rise points to a sustained focus on allocating more resources toward meeting the healthcare requirements of the population.

  • Although the public healthcare ecosystem has seen progress, it continues to manage the needs of a large and varied population, indicating the requirement for continued investment and long-term attention.


Interested in more opportunities? Check out our Upcoming IPO section for new listings and don’t forget to check your IPO allotment status for Gujarat Kidney & Super Speciality IPO.

Explore Other IPOs

  • Current IPOs
  • Upcoming IPOs
  • Closed IPOs
  • IPO Performance
  • All
  • MainBoard
  • SME
Modern Diagnostic AND Research Centre Limited IPO
Bidding Period
31st Dec 2025 - 1st Jan 2026
Price Range
₹85.0 - 90.0
IPO Size
₹36,89,00,000
Aarvee Engineering Consultants Limited IPO
Bidding Period
To Be Announced
Price Range
₹0.0 - 0.0
IPO Size
₹0
Aastha Spintex Limited IPO
Bidding Period
To Be Announced
Price Range
₹0.0 - 0.0
IPO Size
₹0
AceVector Limited IPO
Bidding Period
To Be Announced
Price Range
₹0.0 - 0.0
IPO Size
₹0
Advanced SysTek Limited IPO
Bidding Period
To Be Announced
Price Range
₹0.0 - 0.0
IPO Size
₹0
Advit Jewels Limited IPO
Bidding Period
To Be Announced
Price Range
₹0.0 - 0.0
IPO Size
₹0
Aggcon Equipments International Limited IPO
Bidding Period
To Be Announced
Price Range
₹0.0 - 0.0
IPO Size
₹0
Agilus Diagnostics Limited IPO
Bidding Period
To Be Announced
Price Range
₹0.0 - 0.0
IPO Size
₹0
Airox Technologies Limited IPO
Bidding Period
To Be Announced
Price Range
₹0.0 - 0.0
IPO Size
₹0
Ajay Poly Limited IPO
Bidding Period
To Be Announced
Price Range
₹0.0 - 0.0
IPO Size
₹0
Alcobrew Distilleries India Limited IPO
Bidding Period
To Be Announced
Price Range
₹0.0 - 0.0
IPO Size
₹0
Allchem Lifescience Limited IPO
Bidding Period
To Be Announced
Price Range
₹0.0 - 0.0
IPO Size
₹0
Allied Engineering Works Limited IPO
Bidding Period
To Be Announced
Price Range
₹0.0 - 0.0
IPO Size
₹0
Alpine Texworld Limited IPO
Bidding Period
To Be Announced
Price Range
₹0.0 - 0.0
IPO Size
₹0
Amagi Media Labs Limited IPO
Bidding Period
To Be Announced
Price Range
₹0.0 - 0.0
IPO Size
₹0
Amir Chand Jagadish Kumar Exports Limited IPO
Bidding Period
To Be Announced
Price Range
₹0.0 - 0.0
IPO Size
₹0
Annu Projects Limited IPO
Bidding Period
To Be Announced
Price Range
₹0.0 - 0.0
IPO Size
₹0
AOne Steels India Limited IPO
Bidding Period
To Be Announced
Price Range
₹0.0 - 0.0
IPO Size
₹0
APPL Containers Limited IPO
Bidding Period
To Be Announced
Price Range
₹0.0 - 0.0
IPO Size
₹0
Ardee Engineering Limited IPO
Bidding Period
To Be Announced
Price Range
₹0.0 - 0.0
IPO Size
₹0
NO ACTIVE IPO HERE
  • All
  • MainBoard
  • SME
DACHEPALLI PUBLISHERS LIMITED IPO
Bidding Period
22nd Dec 2025 - 12th Dec 2025
Price Range
₹100.0 - 102.0
IPO Size
₹40,39,00,000
EPW INDIA LIMITED IPO
Bidding Period
22nd Dec 2025 - 12th Dec 2025
Price Range
₹95.0 - 97.0
IPO Size
₹31,81,00,000
GUJARAT KIDNEY AND SUPER SPECIALITY LIMITED IPO
Bidding Period
22nd Dec 2025 - 12th Dec 2025
Price Range
₹108.0 - 114.0
IPO Size
₹2,50,80,00,000
SHYAM DHANI INDUSTRIES LIMITED IPO
Bidding Period
22nd Dec 2025 - 12th Dec 2025
Price Range
₹65.0 - 70.0
IPO Size
₹38,49,00,000
SUNDREX OIL COMPANY LIMITED IPO
Bidding Period
22nd Dec 2025 - 12th Dec 2025
Price Range
₹81.0 - 86.0
IPO Size
₹32,25,00,000
PHYTOCHEM REMEDIES INDIA LIMITED IPO
Bidding Period
18th Dec 2025 - 12th Dec 2025
Price Range
₹98.0 - 98.0
IPO Size
₹38,22,00,000
MARC TECHNOCRATS LIMITED IPO
Bidding Period
17th Dec 2025 - 12th Dec 2025
Price Range
₹88.0 - 93.0
IPO Size
₹42,59,00,000
KSH INTERNATIONAL LIMITED IPO
Bidding Period
16th Dec 2025 - 12th Dec 2025
Price Range
₹365.0 - 384.0
IPO Size
₹7,10,00,00,000
NEPTUNE LOGITEK LIMITED IPO
Bidding Period
15th Dec 2025 - 12th Dec 2025
Price Range
₹126.0 - 126.0
IPO Size
₹46,62,00,000
ASHWINI CONTAINER MOVERS LIMITED IPO
Bidding Period
12th Dec 2025 - 12th Dec 2025
Price Range
₹135.0 - 142.0
IPO Size
₹71,00,00,000
EXIM ROUTES LIMITED IPO
Bidding Period
12th Dec 2025 - 12th Dec 2025
Price Range
₹83.0 - 88.0
IPO Size
₹43,73,00,000
ICICI PRUDENTIAL ASSET MANAGEMENT CO LIMITED IPO
Bidding Period
12th Dec 2025 - 12th Dec 2025
Price Range
₹2061.0 - 2165.0
IPO Size
₹1,06,02,65,00,000
STANBIK AGRO LIMITED IPO
Bidding Period
12th Dec 2025 - 12th Dec 2025
Price Range
₹30.0 - 30.0
IPO Size
₹12,28,00,000
HRS ALUGLAZE LIMITED IPO
Bidding Period
11th Dec 2025 - 12th Dec 2025
Price Range
₹94.0 - 96.0
IPO Size
₹50,92,00,000
PAJSON AGRO INDIA LIMITED IPO
Bidding Period
11th Dec 2025 - 12th Dec 2025
Price Range
₹112.0 - 118.0
IPO Size
₹74,45,00,000
NEPHROCARE HEALTH SERVICES LIMITED IPO
Bidding Period
10th Dec 2025 - 12th Dec 2025
Price Range
₹438.0 - 460.0
IPO Size
₹8,71,05,00,000
PARK MEDI WORLD LIMITED IPO
Bidding Period
10th Dec 2025 - 12th Dec 2025
Price Range
₹154.0 - 162.0
IPO Size
₹9,20,00,00,000
SHIPWAVES ONLINE LIMITED IPO
Bidding Period
10th Dec 2025 - 12th Dec 2025
Price Range
₹12.0 - 12.0
IPO Size
₹56,35,00,000
UNISEM AGRITECH LIMITED IPO
Bidding Period
10th Dec 2025 - 12th Dec 2025
Price Range
₹63.0 - 65.0
IPO Size
₹21,45,00,000
WAKEFIT INNOVATIONS LIMITED IPO
Bidding Period
8th Dec 2025 - 12th Dec 2025
Price Range
₹185.0 - 195.0
IPO Size
₹12,88,89,00,000
  • All
  • MainBoard
  • SME
KSH INTERNATIONAL LIMITED IPO
Issue Prize
384.00
Listing Day Close
354.55(-7.55%)
NEPTUNE LOGITEK LIMITED IPO
Issue Prize
126.00
Listing Day Close
95.80(-23.81%)
ASHWINI CONTAINER MOVERS LIMITED IPO
Issue Prize
142.00
Listing Day Close
140.10(-1.41%)
EXIM ROUTES LIMITED IPO
Issue Prize
88.00
Listing Day Close
115.50(31.82%)
ICICI PRUDENTIAL ASSET MANAGEMENT CO LIMITED IPO
Issue Prize
2165.00
Listing Day Close
2586.70(19.49%)
STANBIK AGRO LIMITED IPO
Issue Prize
30.00
Listing Day Close
33.33(10.00%)
HRS ALUGLAZE LIMITED IPO
Issue Prize
96.00
Listing Day Close
132.30(37.50%)
PAJSON AGRO INDIA LIMITED IPO
Issue Prize
118.00
Listing Day Close
130.20(10.17%)
NEPHROCARE HEALTH SERVICES LIMITED IPO
Issue Prize
460.00
Listing Day Close
471.60(2.61%)
PARK MEDI WORLD LIMITED IPO
Issue Prize
162.00
Listing Day Close
148.15(-8.64%)
SHIPWAVES ONLINE LIMITED IPO
Issue Prize
12.00
Listing Day Close
11.40(-8.33%)
UNISEM AGRITECH LIMITED IPO
Issue Prize
65.00
Listing Day Close
61.75(-4.62%)
WAKEFIT INNOVATIONS LIMITED IPO
Issue Prize
195.00
Listing Day Close
192.30(-1.54%)
RIDDHI DISPLAY EQUIPMENTS LIMITED IPO
Issue Prize
100.00
Listing Day Close
76.00(-24.00%)
PRODOCS SOLUTIONS LIMITED IPO
Issue Prize
138.00
Listing Day Close
151.20(9.42%)
K V TOYS INDIA LIMITED IPO
Issue Prize
239.00
Listing Day Close
336.00(40.59%)
CORONA REMEDIES LIMITED IPO
Issue Prize
1062.00
Listing Day Close
1437.20(35.31%)
ENCOMPASS DESIGN INDIA LIMITED IPO
Issue Prize
107.00
Listing Day Close
193.15(80.37%)
FLYWINGS SIMULATOR TRAINING CENTRE LIMITED IPO
Issue Prize
191.00
Listing Day Close
204.75(7.33%)
METHODHUB SOFTWARE LIMITED IPO
Issue Prize
194.00
Listing Day Close
162.90(-15.98%)

Frequently Asked Questions

What is Gujarat Kidney & Super Speciality Ltd IPO?

Answer Field

Gujarat Kidney & Super Speciality Ltd IPO is a Mainboard IPO of 2,20,00,000 equity shares of a face value of ₹2 aggregating up to ₹250.8 Crores. The issue is priced at ₹108 to ₹114 per share. The minimum order quantity is 128 Shares. The IPO opens on December 22, 2025, and closes on December 24, 2025. MUFG Intime India Pvt Ltd is the registrar for the IPO. The shares are proposed to be listed on BSE,NSE.

When Gujarat Kidney & Super Speciality Ltd IPO will open?

Answer Field

The Gujarat Kidney & Super Speciality Ltd IPO opens on December 22, 2025 and closes on December 24, 2025.

What is the lot size of Gujarat Kidney & Super Speciality Ltd?

Answer Field

Gujarat Kidney & Super Speciality Ltd lot size is 128 shares, and the minimum amount required is ₹14,592.

How to apply for Gujarat Kidney & Super Speciality Ltd IPO?

Answer Field

You can apply in Gujarat Kidney & Super Speciality Ltd IPO online using either UPI or ASBA as payment method. ASBA IPO application is available in the net banking of your bank account. UPI IPO application is offered by brokers who don't offer banking services. To apply for an IPO:

• Login to Bajaj Broking account App/Website & click on IPO

• Enter the number of lots and price at which you wish to apply.

• Enter your UPI ID and click on submit. With this, your bid will be placed with the exchange.

• You will receive a mandate notification to block funds in your UPI app.

• Approve the mandate request on your UPI and funds will be blocked.

When is Gujarat Kidney & Super Speciality Ltd IPO allotment?

Answer Field

The finalization of Basis of Allotment for Gujarat Kidney & Super Speciality Ltd IPO will be done on December 26, 2025, and the allotted shares will be credited to your demat account by December 29, 2025.

When is Gujarat Kidney & Super Speciality Ltd IPO listing date?

Answer Field

The Gujarat Kidney & Super Speciality Ltd listing date is December 30, 2025.

Who is the registrar of Gujarat Kidney & Super Speciality Ltd IPO?

Answer Field

The registrar of Gujarat Kidney & Super Speciality Ltd IPO is MUFG Intime India Pvt Ltd

Which company is the book-running lead manager of the IPO?

Answer Field

Nirbhay Capital Services Pvt ltd will be the book-running lead manager of this IPO.

What is the fresh issue of Gujarat Kidney & Super Speciality Ltd IPO?

Answer Field

The fresh issue size is ₹250.8 Crores equity shares.

What minimum lot size can retail subscribers subscribe to Gujarat Kidney & Super Speciality Ltd?

Answer Field

Retail investors can subscribe to a minimum of one lot, 128 shares and ₹14,592 amount.

How can I approve the UPI mandate request for Gujarat Kidney & Super Speciality Ltd IPO?

Answer Field

To apply for Gujarat Kidney & Super Speciality Ltd IPO, you need to log in to your demat account to complete the bidding process. Then, approve the payment mandate on your UPI app.

What is the price range of Gujarat Kidney & Super Speciality Ltd?

Answer Field

The price of each Gujarat Kidney & Super Speciality Ltd share will be ranging in between ₹108 to ₹114 per share.

What is the cut-off time for the UPI mandate for Gujarat Kidney & Super Speciality Ltd IPO?

Answer Field

The cut-off time for the UPI mandate confirmation is 5:00 PM, December 24, 2025.

No results found

banner-icon

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|

Please Enter Mobile Number

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|